肺癌的特异性主动免疫化疗：一项生存研究。
Specific active immunochemotherapy in lung cancer: a survival study.
作者信息
Stewart T H, Hollinshead A C, Harris J E, Raman S, Bélanger R, Crépeau A, Crook A F, Hirte W E, Hooper D, Klaassen D J, Rapp E F, Sachs H J
出版信息
Can J Surg. 1977 Jul;20(4):370-7.
PMID:301428
Abstract
A radomized clinical trial of chemotherapy, immunization and immunochemotherapy among 55 patients with stages I and II carcinoma of the lung is reported. The survival rate in the immunized groups was significantly better (P = 0.001) than that in the nonimmunized groups. The results are discussed in the light of the reactivity of the patients to the specific cancer antigen.
摘要
报道了一项针对55例I期和II期肺癌患者进行化疗、免疫治疗和免疫化疗的随机临床试验。免疫组的生存率显著高于未免疫组（P = 0.001）。根据患者对特定癌症抗原的反应性对结果进行了讨论。
Zotero 插件